2.59Open2.66Pre Close18 Volume1.10K Open Interest27.50Strike Price4.65KTurnover0.00%IV0.11%PremiumNov 22, 2024Expiry Date2.56Intrinsic Value100Multiplier4DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma9.84Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Pfizer Stock Discussion
bottom or not?
more selling
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet